Amgen, Inc.

NASDAQ: AMGN
$205.41
-$3.47 (-1.7%)
Closing price April 3, 2020
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and ViacomCBS.
Jon C. Ogg
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks appear to be undervalued against the performance of the broader markets.
Jon C. Ogg
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and...
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Jon C. Ogg
Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa.
Jon C. Ogg
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
Chris Lange
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
Chris Lange
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Chris Lange
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Chris Lange
Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals and Sarpeta Therapeutics.
Jon C. Ogg